Schenck H, Müther M, Maragno E, Holling M, Cornelissen M, Haeren R
Department of Neurosurgery, Maastricht University Medical Center, Maastricht, the Netherlands.
School of Mental Health and Neuroscience, Faculty of Health, Medicine and Lifesciences, Maastricht University, Maastricht, the Netherlands.
Brain Spine. 2023 Nov 29;4:102718. doi: 10.1016/j.bas.2023.102718. eCollection 2024.
Determining whether a neurovascular conflict (NVC) involving the anterior visual pathway (AVP) and a non-diseased intracranial artery is amenable for microvascular decompression is challenging. Moreover, it is unclear whether microvascular decompression of the optic nerve is an effective therapy.
What are the outcomes of different treatment strategies for NVCs involving the AVP and a non-diseased intracranial artery?
Data on patients with symptomatic NVCs involving the AVP and a non-diseased intracranial artery was collected and included treatment and outcome parameters. The case series was drafted in accordance with the CARE guidelines.
Three patients aged 53,53 and 55 visited our out-patient clinic with a suspected symptomatic NVC between the optic nerve and a non-diseased intracranial artery. A conservative treatment was opted for in the first patient aimed at treating her glaucoma, with temporary improvement of symptoms. Microvascular decompression of the optic nerve was performed in two patients. One operated patient developed post-operative complications resulting in posterior circulation perfusion decline, while the other experienced a worse tunnel vision with a decrease in visual acuity.
The diagnosis of a symptomatic NVC between the AVP and a non-diseased intracranial artery should be considered with caution, i.e. after exclusion of all other causes. Microvascular decompression can be performed but does not necessarily improve symptoms. A better understanding of the pathophysiological mechanisms underlying these NVCs is warranted to determine the benefit of microvascular decompression of the optic nerve.
确定涉及前视觉通路(AVP)和无病变颅内动脉的神经血管冲突(NVC)是否适合进行微血管减压具有挑战性。此外,视神经微血管减压是否为一种有效疗法尚不清楚。
对于涉及AVP和无病变颅内动脉的NVC,不同治疗策略的结果如何?
收集了有症状的涉及AVP和无病变颅内动脉的NVC患者的数据,包括治疗和结果参数。该病例系列是根据CARE指南起草的。
三名年龄分别为53岁、53岁和55岁的患者因疑似视神经与无病变颅内动脉之间存在有症状的NVC前来我们的门诊就诊。第一名患者选择了旨在治疗其青光眼的保守治疗,症状有暂时改善。两名患者接受了视神经微血管减压术。一名接受手术的患者出现术后并发症,导致后循环灌注下降,而另一名患者视野缺损加重,视力下降。
对于AVP与无病变颅内动脉之间有症状的NVC的诊断应谨慎考虑,即在排除所有其他病因之后。可以进行微血管减压,但不一定能改善症状。有必要更好地了解这些NVC的病理生理机制,以确定视神经微血管减压的益处。